NCBiotech News

Pathalys Pharma, a newly formed RTP biopharmaceutical company developing therapies for chronic kidney disease, has announced its executive leadership team, led by pharma veteran Neal Fowler.

Newly minted RTP cancer therapeutics developer Incyclix Bio has just received $30 million in Series B financing.

A team of North Carolina scientists, with early grant support from NCBiotech, has developed an implantable scaffold resembling a “mini marshmallow” that produces and releases CAR-T cells for attacking cancerous tumors.

Flush with cash, thanks in part to an early NCBiotech loan that helped spark a Series A and, now B round of funding, Duke spinout Lindy Biosciences is getting ready to scale.

Durham-based food technology startup Pairwise has launched a new brand, and a brand new product -- Conscious Foods and Conscious Greens.

Baebies Inc., a medical device and diagnostics company in Durham, has received regulatory clearance to commercialize a test for the COVID-19 virus in Europe.

NCBiotech has launched the NC BIONEER Venture Challenge to support life sciences startup commercialization, innovators, entrepreneurs, and companies across North Carolina.

City of Durham leaders have launched the Build Up Local Life Sciences (BULLS) initiative to help underrepresented young people connect with careers in the life sciences, including pharmaceutical manufacturing.

With impact investing on the rise, many of the nation’s top healthcare foundations are ramping up their ground game in the Triangle, tapping everything from talent to solutions, to tackle growing health disparities across the country.

Durham Tech and Wake Tech have launched RTP Bio, a workforce development collaboration that will unite the schools’ biotechnology, biomanufacturing and biopharmaceutical talent pipelines with the help of an ongoing funding pledge from major North Carolina newcomer Lilly.

TAIJI Medical Supplies of Lincolnton and Greensboro-based Carolina Liquid Chemistries Corp. have partnered to provide surgical face masks to hospitals, surgery centers, dentists’ offices and other health care facilities throughout the United States.

North Carolina is taking the next big step as a global life sciences leader with our submission of a Phase 2 proposal for a major federal Economic Development Administration Build Back Better Regional Challenge grant.

The Mosaic Company has acquired Plant Response as part of an ongoing strategy to build up its presence in soil-health products.

$23 million in new funding will help beef up British cancer diagnostics startup Biofidelity’s U.S. headquarters activity in RTP as it prepares to launch its first commercial product.

OpenDoors, a nonprofit aimed at promoting workforce diversity among the Triangle’s life sciences companies through paid internships is launching this week.